Claire Bonfils

1.3k total citations
25 papers, 1.1k citations indexed

About

Claire Bonfils is a scholar working on Molecular Biology, Cell Biology and Cancer Research. According to data from OpenAlex, Claire Bonfils has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Cell Biology and 6 papers in Cancer Research. Recurrent topics in Claire Bonfils's work include Histone Deacetylase Inhibitors Research (9 papers), Protein Degradation and Inhibitors (6 papers) and Microtubule and mitosis dynamics (5 papers). Claire Bonfils is often cited by papers focused on Histone Deacetylase Inhibitors Research (9 papers), Protein Degradation and Inhibitors (6 papers) and Microtubule and mitosis dynamics (5 papers). Claire Bonfils collaborates with scholars based in Canada, United States and Switzerland. Claire Bonfils's co-authors include Jeffrey M. Besterman, Zuomei Li, Ann Kalita, A. Robert MacLeod, Marielle Fournel, Marja Dubay, Gregory K. Reid, Marie-Claude Trachy-Bourget, Robert E. Martell and Jubrail Rahil and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Claire Bonfils

24 papers receiving 1.0k citations

Peers

Countries citing papers authored by Claire Bonfils

Since Specialization

Citations

This map shows the geographic impact of Claire Bonfils's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Bonfils with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Bonfils more than expected).

Fields of papers citing papers by Claire Bonfils

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Bonfils. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Bonfils. The network helps show where Claire Bonfils may publish in the future.

Co-authorship network of co-authors of Claire Bonfils

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Bonfils. A scholar is included among the top collaborators of Claire Bonfils based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Bonfils. Claire Bonfils is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract P200: Pre-clinical development of a dopamine receptor 2, PD-1 and CD47 trispecific antibody for treatment of small cell lung cancer 2021 ·Molecular Cancer Therapeutics ·S. C. Yao, Yun Cui, (unknown), Liying Gong, Claire Bonfils, (unknown), Emily Chen, Elijus Undzys, (unknown), (unknown), Hiba Ahmad Zahreddine, (unknown), (unknown), (unknown), (unknown), Carl M. Gay, Lauren A. Byers, (unknown), (unknown), David Young	1
2	Abstract 930: Preclinical characterization of MG516, a novel inhibitor of receptor tyrosine kinases involved in resistance to targeted therapies. 2013 ·Cancer Research ·Normand Beaulieu, (unknown), Claire Bonfils, Michael R. Mannion, Stéphane Raeppel, (unknown), Stephen Claridge, (unknown), Franck Raeppel, Arkadii Vaisburg, James Wang, Marielle Fournel, Jeffrey M. Besterman, Christiane R. Maroun	5
3	312 A Novel Assay for the Met Inhibitory Activity of MGCD265 in Plasma From Solid Tumor Patients in a Dose Escalating Phase I Study 2012 ·European Journal of Cancer ·Marielle Fournel, (unknown), Nancy Beaulieu, Claire Bonfils, Herbert I. Hurwitz, Geoffrey I. Shapiro, C. Kollmannsberger, (unknown), Jeffrey M. Besterman, Christiane R. Maroun	4
4	Abstract 1790: The combination of MGCD265, a Met/VEGFR inhibitor in clinical development, and erlotinib potently inhibits tumor growth by altering multiple pathways including glycolysis 2012 ·Cancer Research ·Claire Bonfils, Normand Beaulieu, Marielle Fournel, Hélène Ste-Croix, Jeffrey M. Besterman, Christiane R. Maroun	13
5	MGCD265, a multitargeted oral tyrosine kinase receptor inhibitor of Met and VEGFR: Dose-escalation phase I study. 2012 ·Journal of Clinical Oncology ·Christian Kollmannsberger, Herbert I. Hurwitz, James M. Cleary, John H. Strickler, Michel Drouin, (unknown), (unknown), Gregory K. Reid, Christiane R. Maroun, Claire Bonfils, James Wang, (unknown), Jeffrey M. Besterman, (unknown), Geoffrey I. Shapiro	1
6	Determination of the maximum tolerated dose (MTD) of MGCD265, an oral Met/VEGFR multitargeted receptor tyrosine kinase inhibitor, in combination with docetaxel. 2011 ·Journal of Clinical Oncology ·Drew Rasco, Amita Patnaik, Ravi K. Amaravadi, Kyriakos P. Papadopoulos, (unknown), Anthony W. Tolcher, Muralidhar Beeram, (unknown), Michel Drouin, (unknown), (unknown), (unknown), Christiane R. Maroun, Claire Bonfils, (unknown), Jeffrey M. Besterman, P J O’Dwyer	2
7	Potent preclinical antitumor activity of MGCD265, an oral Met/VEGFR kinase inhibitor in phase II clinical development, in combination with taxanes or erlotinib. 2010 ·Journal of Clinical Oncology ·Jeffrey M. Besterman, Marielle Fournel, Isabelle Dupont, Claire Bonfils, Marja Dubay, Hélène Ste-Croix, Christiane R. Maroun	17
8	Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia 2009 ·British Journal of Haematology ·Kristie A. Blum, (unknown), (unknown), Richard van der Jagt, Joseph Brandwein, Suman Kambhampati, Jeannine Kassis, Melanie E. Davis, Claire Bonfils, Marja Dubay, (unknown), Michel Drouin, David Lucas, Robert E. Martell, John C. Byrd	94
9	Induction of an anti-angiogenesis factor, Thrombospondin 1 (TSP-1), by a novel histone deacetylase inhibitor, MGCD0103, in human cancer cells in vitro and in vivo 2008 ·Cancer Research ·Jianhong Liu, Claire Bonfils, Marja Dubay, Hannah Nguyen, Guillermo Garcia‐Manero, Allen S. Yang, (unknown), Robert E. Martell, Jeffrey M. Besterman, Zuomei Li	1
10	Evaluation of the Pharmacodynamic Effects of MGCD0103 from Preclinical Models to Human Using a Novel HDAC Enzyme Assay 2008 ·Clinical Cancer Research ·Claire Bonfils, Ann Kalita, Marja Dubay, Lillian L. Siu, Michael A. Carducci, Gregory K. Reid, Robert E. Martell, Jeffrey M. Besterman, Zuomei Li	81
11	Pharmacological inhibition of histone deacetylases for the treatment of cancer, neurodegenerative disorders and inflammatory diseases 2008 ·Expert Opinion on Drug Discovery ·Claire Bonfils, Donald R. Walkinshaw, Jeffrey M. Besterman, Xiang-Jiao Yang, Zuomei Li	7
12	MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo 2008 ·Molecular Cancer Therapeutics ·Marielle Fournel, Claire Bonfils, Yu Hou, Pu Yan, Marie-Claude Trachy-Bourget, Ann Kalita, Jianhong Liu, Aihua Lu, (unknown), Marie‐France Robert, Jeffrey Gillespie, Jinru Wang, Hélène Ste-Croix, Jubrail Rahil, Sylvain Lefèbvre, Oscar Moradei, Daniel Delorme, A. Robert MacLeod, Jeffrey M. Besterman, Zuomei Li	271
13	Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia 2008 ·Blood ·Guillermo Garcia‐Manero, Sarit Assouline, Jörge E. Cortes, Zeev Estrov, Hagop M. Kantarjian, Hui Yang, Willie Newsome, Wilson H. Miller, Caroline Rousseau, Ann Kalita, Claire Bonfils, Marja Dubay, (unknown), Zuomei Li, Jeffrey M. Besterman, Gregory K. Reid, Eric Laille, Robert E. Martell, Mark D. Minden	194
14	A phase I pharmacokinetic and pharmacodynamic study of the DNA methyltransferase 1 inhibitor MG98 administered twice weekly 2003 ·Annals of Oncology ·David J. Stewart, Ross C. Donehower, Elizabeth A. Eisenhauer, Nancy Wainman, Ajit Shah, Claire Bonfils, A. Robert MacLeod, Jeffrey M. Besterman, Gregory K. Reid	77
15	Biphasic expression of rnrB in Dictyostelium discoideum suggests a direct relationship between cell cycle control and cell differentiation 2001 ·Differentiation ·Harry K. MacWilliams, (unknown), Pascale Gaudet, Claire Bonfils, Adrian Tsang	14
16	Characterization of the Human DNA Methyltransferase Splice Variant Dnmt1b 2000 ·Journal of Biological Chemistry ·Claire Bonfils, Normand Beaulieu, Eric Y. Chan, (unknown), A. Robert MacLeod	33
17	Identification of cis-Regulating Elements andtrans-Acting Factors Regulating the Expression of the Gene Encoding the Small Subunit of Ribonucleotide Reductase inDictyostelium discoideum 1999 ·Journal of Biological Chemistry ·Claire Bonfils, Pascale Gaudet, Adrian Tsang	8
18	A prespore-specific gene ofDictyostelium discoideum encodes the small subunit of ribonucleotide reductase 1996 ·Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·Adrian Tsang, Claire Bonfils, (unknown), (unknown), Caroline E. Grant	10
19	Expression and characterization of a dictyostelium discoideum annexin 1994 ·Molecular and Cellular Biochemistry ·Claire Bonfils, Michael T. Greenwood, Adrian Tsang	23
20	A 27-bp deletion is responsible for the expression of a variant CABP1, a cyclic AMP-binding protein of Dictyostelium discoideum 1991 ·Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·Claire Bonfils, Jean M. Hébert, Adrian Tsang	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact